Royal Melbourne Hospital; Hematology and Medical Oncology
Parkville, Victoria, Australia
Hospital department in Parkville, Victoria
Parkville VIC 3050
About Royal Melbourne Hospital; Hematology and Medical Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Pfizer
2
Genentech, Inc.
1
Clinical Trials at Royal Melbourne Hospital; Hematology and Medical Oncology
During the past decade, Royal Melbourne Hospital; Hematology and Medical Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial
2008-06-01
2013-08-01
Completed
45
Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase
2008-12-01
2013-05-01
Completed
31
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
2009-06-29
2015-09-09
Completed
921
A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors
2010-07-27
2017-05-02
Completed
45
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
2012-01-20
2016-03-30
Completed
501
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
2013-12-05
2016-11-04
Completed
50
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
2016-06-07
2022-07-07
Completed
403
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Royal Melbourne Hospital; Hematology and Medical Oncology
According to Clinical.Site data, the most researched conditions in "Royal Melbourne Hospital; Hematology and Medical Oncology" are
"Gaucher Disease" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Glioblastoma" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Royal Melbourne Hospital; Hematology and Medical Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Royal Melbourne Hospital; Hematology and Medical Oncology
Most popular intervention types in "Royal Melbourne Hospital; Hematology and Medical Oncology" are "Drug" (8 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Docetaxel" (2 trials), "Nab-paclitaxel" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Royal Melbourne Hospital; Hematology and Medical Oncology
The vast majority of trials in "Royal Melbourne Hospital; Hematology and Medical Oncology" are
8 trials for "All" genders.
Clinical Trials Status at Royal Melbourne Hospital; Hematology and Medical Oncology
Currently, there are NaN active trials in "Royal Melbourne Hospital; Hematology and Medical Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Royal Melbourne Hospital; Hematology and Medical Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Royal Melbourne Hospital; Hematology and Medical Oncology, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".